KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) Gross Margin (2016 - 2025)

Elevance Health (ELV) has disclosed Gross Margin for 17 consecutive years, with 89.37% as the latest value for Q2 2025.

  • On a quarterly basis, Gross Margin changed N/A to 89.37% in Q2 2025 year-over-year; TTM through Jun 2025 was 73.69%, a N/A change, with the full-year FY2024 number at 88.84%, down 106.0% from a year prior.
  • Gross Margin was 89.37% for Q2 2025 at Elevance Health, roughly flat from 89.81% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 91.85% in Q3 2021 to a low of 20.61% in Q4 2021.
  • A 5-year average of 44.03% and a median of 26.56% in 2021 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: tumbled -11269bps in 2021, then soared 7640bps in 2023.
  • Elevance Health's Gross Margin stood at 20.61% in 2021, then soared by 209bps to 22.43% in 2022, then surged by 296bps to 88.9% in 2023, then crashed by -70bps to 26.95% in 2024, then soared by 232bps to 89.37% in 2025.
  • Per Business Quant, the three most recent readings for ELV's Gross Margin are 89.37% (Q2 2025), 89.81% (Q1 2025), and 26.95% (Q3 2024).